English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

In summary, CAP-T cells present a highly efficient transient expression system enabling the generation of mg amounts of the protein of interest for early research and development within only two weeks from gene to product. Furthermore, CAP-T cell produced proteins showed fully human posttranslational modification pattern, which was also observed for the original human CAP cells, the CAP-T cells were derived from. The CAP technology based on CAP-T cells for transient transfection and CAP cells for stable protein production [1] therefore provides a unique system in which the whole process from early research to production of therapeutic proteins can be run through with the same cell type.

CAP-T cell expression system: a novel rapid and versatile human cell expression system for fast and high yield transient protein expression